Manfredi nicoletti biography of george
•
Approximately 22,500 architects convened in San Francisco for the 2009 AIA Convention.
Jessica Sheridan
PLENARY & PENURY
The most remarkable aspect of the 2009 AIA Convention in San Francisco was that despite near-record attendance, many AIA members were able to participate in the plenary sessions and continuing education seminars from home. From the podium at the Moscone Center, AIA President Marvin Malecha, FAIA, spoke of a symposium where 14 people were in the room, while over 14,000 participated electronically. Questions were asked online and through Twitter, and the Tweet sounds of pluralist participation, at 140 characters högsta, kept the grandstanding and pontificating to the minimum, except at Saturday’s Business Session. While overall attendance surpassed 20,000 people, and the product exhibition space was sold out, revenue was down, and many who were in Boston could not afford to attend because of the state of the economy and the liquidity of their firms.
HONORS & • The Cultural Centre and the Millennium Tower of Nigeria, together with the National Square will make up a harmonious complex which will improve the quality of the City of Abuja. It is anambitious proposal that extends two adjoining plots in the cultural, religious and administrative heart of the city. It is a refreshing approach that is in direct opposition to the traditional architecture linked with the colonial idioms, even though the Nigerian tradition inspires the design. Within this ambitious project is the Millennium Tower, a 170m high observatory tower that stands out as a symbolic hug with which all Nigerian ethnic groups will identify. The entire complex (Cultural Center, Millennium Tower & National square) will be a centre of cultural rejuvenation. The design of the tower illustrates three 100m high transparent ‘leaves’ which envelope monumental ‘stones’ depicting the sacred flower of the Fo • Published in final edited form as: Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1679–1681. doi: 10.1161/ATVBAHA.110.209668 Immunology has recently penetrated the field of atherothrombosis. A number of human and experimental studies have documented that both cellular and molecular immune effectors are involved at various stages of the pathological process 1. This has directed our attention towards the use in atherothrombosis of immunomodulatory strategies, commonly employed for the prevention and treatment of other chronic inflammatory diseases. The administration of immunosuppressive drugs is the most common approach for treating immune-mediated diseases. However, the long-term administration of non-antigen-specific agents that cannot distinguish between beneficial and destructive immune responses is a major drawback of this strategy. Interesting alternatives consist of strategies aimed at potentiating the physiological reg Nigerian Cultural Centre and Millenium Tower / Studio Nicoletti Associati